In a strategic move that strengthens AI-driven scientific discovery, SandboxAQ, the quantitative AI leader helmed by tech visionary Jack Hidary, has expanded its alliance with global consulting firm Deloitte. The collaboration brings SandboxAQ’s cutting-edge AI simulation software, powered by Large Quantitative Models (LQMs), to a broader range of industries, including biopharma, energy, and materials science.
The partnership integrates SandboxAQ’s AI-driven molecular simulation solutions—AQBioSim and AQChemSim—with Deloitte’s deep expertise in data science, life sciences, and technology consulting. This synergy aims to accelerate drug discovery, enhance materials science, and revolutionize healthcare innovations by leveraging the power of LQMs.
LQMs: The Next Evolution in AI
Large Language Models (LLMs) have dominated AI advancements for the past two years, but are now becoming commoditized. LQMs represent the next transformative leap in artificial intelligence. These models, which underpin SandboxAQ’s offerings, enable precise, physics-based simulations that facilitate groundbreaking research in biopharma and other sectors, because they are trained on chemistry, math and physics.
“SandboxAQ is excited to expand its long-standing strategic alliance with Deloitte, whose relationships with some of the world’s largest organizations will accelerate the adoption of our quantitative AI technologies,” said Andrew McLaughlin, Chief Operating Officer of SandboxAQ. “AI simulation with Large Quantitative Models represents the next evolution of AI and will have a transformative impact on how organizations create value for their customers in ways that Large Language Models cannot.”
Driving Innovation in Drug Discovery
By integrating LQMs with Deloitte’s Atlas AI™ knowledge graph technology, the partnership will empower scientists to extract new clinical hypotheses from literature with unprecedented accuracy. The AI-driven approach is designed to streamline exploratory data analysis, AI model evaluation, and hypothesis testing, ultimately accelerating drug discovery and optimizing treatment responses.
“With this expansion of our alliance, we’re able to combine our extensive experience in life sciences, data, and research with SandboxAQ’s leadership in AI simulation and Large Quantitative Models,” said Aditya Kudumala, principal at Deloitte Consulting LLP. “Together, we aim to advance drug discovery and materials science for leading academic, commercial, and public sector entities.”
Move Expands on Recent Funding and Google Cloud Momentum
SandboxAQ spun out of Alphabet in March, 2022 and is now valued at more than $5.6B. In January, SandboxAQ announced a partnership with Google Cloud to integrate and optimize its Large Quantitative Models (LQMs) on Google Cloud’s infrastructure. This collaboration aims to accelerate the development and deployment of SandboxAQ’s quantitative AI solutions across various industries, including drug discovery, chemical and materials science, advanced sensing, and cybersecurity. By leveraging Google Cloud’s AI-optimized infrastructure and Marketplace, SandboxAQ intends to bring its innovative models to enterprise customers more efficiently.
